By Chase Doyle
Originally published by our sister publication Clinical Oncology News
Research has shown adjuvant hormone therapy can greatly improve disease-free survival in patients with estrogen receptor (ER)-positive breast cancer. Now, new research shows hot flashes caused by the therapy may lead to worse outcomes (J Natl Compr Canc Net 2022 Apr 6. doi:10.6004/jnccn.2021.7116).